These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 29636115)
41. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma. Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801 [TBL] [Abstract][Full Text] [Related]
42. Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review). Bryukhovetskiy I; Bryukhovetskiy A; Khotimchenko Y; Mischenko P Oncol Rep; 2016 Feb; 35(2):639-48. PubMed ID: 26548844 [TBL] [Abstract][Full Text] [Related]
43. Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes. Cusulin C; Chesnelong C; Bose P; Bilenky M; Kopciuk K; Chan JA; Cairncross JG; Jones SJ; Marra MA; Luchman HA; Weiss S Stem Cell Reports; 2015 Jul; 5(1):1-9. PubMed ID: 26095605 [TBL] [Abstract][Full Text] [Related]
44. Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication. Iwadate Y Neurol Med Chir (Tokyo); 2018 Feb; 58(2):61-70. PubMed ID: 29129882 [TBL] [Abstract][Full Text] [Related]
45. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents. Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642 [TBL] [Abstract][Full Text] [Related]
46. Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR Tome-Garcia J; Tejero R; Nudelman G; Yong RL; Sebra R; Wang H; Fowkes M; Magid M; Walsh M; Silva-Vargas V; Zaslavsky E; Friedel RH; Doetsch F; Tsankova NM Stem Cell Reports; 2017 May; 8(5):1421-1429. PubMed ID: 28434940 [TBL] [Abstract][Full Text] [Related]
47. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness. Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038 [TBL] [Abstract][Full Text] [Related]
48. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells. Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313 [TBL] [Abstract][Full Text] [Related]
49. Therapeutic potential of targeting glucose metabolism in glioma stem cells. Nakano I Expert Opin Ther Targets; 2014 Nov; 18(11):1233-6. PubMed ID: 25077882 [TBL] [Abstract][Full Text] [Related]
50. IQGAP1 protein specifies amplifying cancer cells in glioblastoma multiforme. Balenci L; Clarke ID; Dirks PB; Assard N; Ducray F; Jouvet A; Belin MF; Honnorat J; Baudier J Cancer Res; 2006 Sep; 66(18):9074-82. PubMed ID: 16982749 [TBL] [Abstract][Full Text] [Related]
51. DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastoma. Mansouri S; Singh S; Alamsahebpour A; Burrell K; Li M; Karabork M; Ekinci C; Koch E; Solaroglu I; Chang JT; Wouters B; Aldape K; Zadeh G Oncotarget; 2016 Aug; 7(35):56431-56446. PubMed ID: 27421140 [TBL] [Abstract][Full Text] [Related]
52. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Kang MK; Kang SK Stem Cells Dev; 2007 Oct; 16(5):837-47. PubMed ID: 17999604 [TBL] [Abstract][Full Text] [Related]
53. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
54. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
55. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion. Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154 [TBL] [Abstract][Full Text] [Related]
56. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis. Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119 [TBL] [Abstract][Full Text] [Related]
57. The complement system in glioblastoma multiforme. Bouwens van der Vlis TAM; Kros JM; Mustafa DAM; van Wijck RTA; Ackermans L; van Hagen PM; van der Spek PJ Acta Neuropathol Commun; 2018 Sep; 6(1):91. PubMed ID: 30208949 [TBL] [Abstract][Full Text] [Related]
58. Self-functional gold nanoprobes for intra-nuclear epigenomic monitoring of cancer stem-like cells. Verma AH; Ganesh S; Venkatakrishnan K; Tan B Biosens Bioelectron; 2022 Jan; 195():113644. PubMed ID: 34571478 [TBL] [Abstract][Full Text] [Related]
59. [Genomic and Epigenomic Analysis of Brain Tumor:Focus on Glioma]. Mukasa A No Shinkei Geka; 2020 Feb; 48(2):103-115. PubMed ID: 32094309 [No Abstract] [Full Text] [Related]